Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Rizatriptan
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Rizatriptan 10mg orodispersible tablets sugar free
0407041R0AAADAD
|
Rizatriptan | Rizatriptan | Central Nervous System | 36,238 |
|
Rizatriptan 10mg tablets
0407041R0AAABAB
|
Rizatriptan | Rizatriptan | Central Nervous System | 27,977 |
|
Rizatriptan 10mg oral lyophilisates sugar free
0407041R0AAACAC
|
Rizatriptan | Rizatriptan | Central Nervous System | 21,483 |
|
Maxalt Melt 10mg oral lyophilisates
0407041R0BBACAC
|
Maxalt | Rizatriptan | Central Nervous System | 10,057 |
|
Rizatriptan 5mg tablets
0407041R0AAAAAA
|
Rizatriptan | Rizatriptan | Central Nervous System | 5,027 |
|
Maxalt 10mg tablets
0407041R0BBABAB
|
Maxalt | Rizatriptan | Central Nervous System | 1,460 |
|
Maxalt 5mg tablets
0407041R0BBAAAA
|
Maxalt | Rizatriptan | Central Nervous System | 351 |
|
Rizatriptan 5mg orodispersible tablets sugar free
0407041R0AAAEAE
|
Rizatriptan | Rizatriptan | Central Nervous System | 7 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.